4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-23-005251
Options or other derivatives
- Chief Executive Officer acquired 242,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BLATT LAWRENCE Chief Executive Officer | 2023-03-15 | Grant or award · Stock Option (Right to Buy) | +242,500 | 242,500 | D | ||
Loading xslF345X03/doc1.xml…